Generic Price Cliff · method and verification
The method was frozen on 12 November 2026. The file's SHA-256 hash begins e59f5eeba242, and the original, before the amendment, began b7749c62cc15. The tool refuses to build if the method file no longer matches its hash.
| Measure | Result |
|---|---|
| Eligible products compared | 200 |
| Curve years compared | 14 |
| Mismatches | 0 |
A separate Python reader rebuilt the eligible product set and the whole curve from the stored NADAC snapshot rows and the raw Orange Book files. Its first run found a matching defect in the builder, recorded as protocol amendment 1; after the fix the two agree.
The checking led to one amendment to the method, dated and recorded:
2026-11-12 (amendment 1, before any publication of the cliff statistics): the independent control in section 4.1 found that the first version of the matching let "AMOXICILLIN 250 MG CAPSULE" match the three-drug combination group "amoxicillin; clarithromycin; lansoprazole", because the single-ingredient amoxicillin capsule group has no dated brand approval and so the combination was the only candidate. The matching rule in section 1 is clarified: an Orange Book group matches only if its ingredient text is a single ingredient (no semicolon; a salt or ester suffix after the NADAC drug name is allowed, a second active ingredient is not), and its form text contains exactly one of TABLET or CAPSULE (kits and mixed-form groups are excluded). A NADAC product whose only candidate is a combination or mixed-form group is dropped as "no unique match". With the clarified rule the independent reader and the builder agree. The original protocol hash is kept in PROTOCOL-GENERIC-CLIFF-2026-11-12.original.sha256.
Matching is by name and form kind only, not by strength; a product on a strength the first generic did not cover can enter later. The Orange Book dates the first approval, not the first sale. NADAC year-end snapshots are one week in 52. Survivorship: products priced in later years are the ones still on the market. The selection is tablets and capsules with a unique match, a minority of all products.
The source data is public: see the FDA generic drug facts. The dataset, the method and the code that rebuilds it are published at doi:10.5281/zenodo.24182324. Open the Generic Price Cliff to see the result.
The method was written, hashed and saved before any figure from the data was published. A change after that is an amendment with a date, and the original hash is kept, so anyone can see what was decided and when.
A tool can agree with itself and still be wrong. A separate reader, written without the builder's code, recomputes the figures from the raw files; where the two disagree, one of them has a defect.
No. It means the numbers match an independent recomputation under the stated method. The limits section lists what the method does not cover.
Further reading: Zenodo, where the datasets are deposited; the FAIR data principles; the National Academies on reproducibility; the author's ORCID record; the FDA generic drug facts.
Compiled by Vincent Wesley Couey (ORCID 0009-0005-6869-308X).